A Laboratory Model for Heroin Abuse Medications - 8

Completed · Phase 2

Conditions studied: Heroin Dependence, Opioid-Related Disorders, Substance-Related Disorders

In brief

The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."

Key facts

Study ID

NCT00000273

Run by

New York State Psychiatric Institute

People needed

8

Starts

1995-08-01

Expected to finish

2005-11-01

Last updated by the study team

2017-07-05

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Columbia University — New York, New York, United States
• New York State Psychiatric Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.